Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
Hepatol Commun. 2023 Mar 24;7(4). doi: 10.1097/HC9.0000000000000097. eCollection 2023 Apr 1.
Since its release as a "research preview" in November 2022, ChatGPT, the conversational interface to the Generative Pretrained Transformer 3 large language model built by OpenAI, has garnered significant publicity for its ability to generate detailed responses to a variety of questions. ChatGPT and other large language models generate sentences and paragraphs in response to word patterns in training data that they have previously seen. By allowing users to communicate with an artificial intelligence model in a human-like way, however, ChatGPT has crossed the technological adoption barrier into the mainstream. Existing examples of ChatGPT use-cases, such as negotiating bills, debugging programing code, and writing essays, indicate that ChatGPT and similar models have the potential to have profound (and yet unknown) impacts on clinical research and practice in hepatology. In this special article, we discuss the general background and potential pitfalls of ChatGPT and associated technologies-and then we explore its uses in hepatology with specific examples.
自 2022 年 11 月作为“研究预览版”发布以来,OpenAI 开发的基于生成式预训练转换器 3 的大型语言模型的对话界面 ChatGPT 因其能够对各种问题生成详细回答而引起了广泛关注。ChatGPT 和其他大型语言模型根据其之前见过的训练数据中的单词模式生成句子和段落。然而,通过允许用户以类似于人类的方式与人工智能模型进行交互,ChatGPT 已经跨越了技术采用障碍进入主流。ChatGPT 的现有用例示例,如协商账单、调试编程代码和撰写论文,表明 ChatGPT 和类似模型有可能对肝脏病学的临床研究和实践产生深远(且未知)的影响。在这篇专题文章中,我们讨论了 ChatGPT 和相关技术的一般背景和潜在陷阱,然后我们用具体示例探讨了它在肝脏病学中的用途。